-
公开(公告)号：US07538101B2
公开(公告)日：2009-05-26
申请号：US11605005
申请日：2006-11-28
申请人： Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Rosa Maria Rodriguez Sarmiento , Sven Taylor
发明人： Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Rosa Maria Rodriguez Sarmiento , Sven Taylor
IPC分类号： A01N43/00 , A61K31/54 , A61K31/55 , C07D223/00 , C07D279/00 , C07D285/00 , C07D295/00
CPC分类号： C07D401/12 , C07D401/14 , C07D403/12
摘要： The present invention relates to compounds of formula I wherein R1, R2 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中R 1，R 2和G如说明书和权利要求及其药学上可接受的盐所定义。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US07534788B2
公开(公告)日：2009-05-19
申请号：US12173888
申请日：2008-07-16
申请人： Peter Mohr , Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Tadakatsu Takahashi , Sven Taylor
发明人： Peter Mohr , Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Tadakatsu Takahashi , Sven Taylor
IPC分类号： A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/4545 , C07D405/06 , C07D409/06
CPC分类号： C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要： The present invention relates to compounds of formula I wherein X, A and R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中X，A和R 1至R 4如说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US07507736B2
公开(公告)日：2009-03-24
申请号：US12019682
申请日：2008-01-25
IPC分类号： A61K31/454 , A61K31/496 , C07D401/12 , C07D451/06
CPC分类号： C07D401/12 , C07D401/02 , C07D401/14 , C07D451/06
摘要： The present invention relates to compounds of formula I wherein A and R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中A和R 1至R 4如说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US07388095B2
公开(公告)日：2008-06-17
申请号：US11604563
申请日：2006-11-27
IPC分类号： C07D417/14 , C07D413/14 , C07D401/14
CPC分类号： C07D401/12 , C07D451/06
摘要： The present invention relates to compounds of formula I wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中R 1至R 4和G如说明书和权利要求及其药学上可接受的盐所定义。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US07723325B2
公开(公告)日：2010-05-25
申请号：US12493516
申请日：2009-06-29
IPC分类号： A61K31/4439 , A61K31/5355 , A61K31/541 , C07D295/192 , C07D401/14 , C07D413/14
CPC分类号： C07D401/06 , C07D209/42 , C07D401/14 , C07D403/06 , C07D405/12 , C07D487/04 , C07D491/113
摘要： The present invention relates to compounds of formula I wherein G and R1 to R5 and R12 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中G和R 1至R 5和R 12如说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
6.发明授权公开(公告)号：US07648979B2
公开(公告)日：2010-01-19
申请号：US12020637
申请日：2008-01-28
IPC分类号： A61K31/404 , A61P3/04 , C07D401/04 , C07D209/42
CPC分类号： C07D209/42 , C07D401/04 , C07D403/06
摘要： The present invention relates to compounds of formula I wherein A, G and R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中A，G和R 1至R 3如说明书和权利要求中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US20090264418A1
公开(公告)日：2009-10-22
申请号：US12493516
申请日：2009-06-29
IPC分类号： A61K31/551 , C07D417/14 , A61K31/541 , C07D403/14 , A61K31/496 , C07D401/14 , C07D413/14 , A61K31/5377 , A61K31/4545 , C07D243/08 , A61P3/04 , A61P25/00
CPC分类号： C07D401/06 , C07D209/42 , C07D401/14 , C07D403/06 , C07D405/12 , C07D487/04 , C07D491/113
摘要： The present invention relates to compounds of formula I wherein G and R1 to R5 and R12 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中G和R 1至R 5和R 12如说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US20080188484A1
公开(公告)日：2008-08-07
申请号：US12019682
申请日：2008-01-25
IPC分类号： A61K31/496 , C07D401/02
CPC分类号： C07D401/12 , C07D401/02 , C07D401/14 , C07D451/06
摘要： The present invention relates to compounds of formula I wherein A and R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中A和R 1至R 4如在说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US20070123526A1
公开(公告)日：2007-05-31
申请号：US11605005
申请日：2006-11-28
申请人： Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Rosa Rodriguez Sarmiento , Sven Taylor
发明人： Matthias Nettekoven , Jean-Marc Plancher , Hans Richter , Olivier Roche , Rosa Rodriguez Sarmiento , Sven Taylor
IPC分类号： A61K31/541 , C07D417/14
CPC分类号： C07D401/12 , C07D401/14 , C07D403/12
摘要： The present invention relates to compounds of formula I wherein R1, R2 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中R 1，R 2和G如说明书和权利要求及其药学上可接受的盐所定义。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
公开(公告)号：US20090156583A1
公开(公告)日：2009-06-18
申请号：US12389619
申请日：2009-02-20
IPC分类号： A61K31/4985 , C07D471/14 , C07D471/04 , C07D487/04 , A61K31/551
CPC分类号： C07D487/04 , C07D471/14
摘要： The present invention relates to compounds of formula I wherein A, G, r and R1 to R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
摘要翻译： 本发明涉及式I化合物，其中A，G，r和R 1至R 5如说明书和权利要求书中所定义，及其药学上可接受的盐。 该化合物可用于治疗和/或预防与H3受体的调节相关的疾病。
-
-
-
-
-
-
-
-
-
搜索结果
167 条记录 (耗时 0.039 秒)
